Monograph: Ranibizumab (USAN)

Ranibizumab (USAN)

This content is only available to registered users

If you’re visiting this website the first time and would like to test the database free of charge for ten days, then click here to register once. After you’ve registered, log in with your user name and password.

You’re already registered with DrugBase and would like to test the database free of charge for ten days without any further commitment? Then log in here with your access data and select the database you wish to test.
Latin:
Ranibizumabum
German:
Ranibizumab
French:
Ranibizumab
Spanish:
Ranibizumab

Therapeutical categories:

Angiogenesis inhibitor
Monoclonal antibody
Ophthalmic agent
Treatment of diabetic retinopathy
Treatment of neovascular (wet) age-related macular degeneration
Vascular endothelial growth factor (VEGF) antagonist

ATC:

CAS-No.:

0347396-82-1